[PDF][PDF] Simplified criteria for the diagnosis of autoimmune hepatitis
EM Hennes, M Zeniya, AJ Czaja, A Parés… - …, 2008 - Wiley Online Library
Diagnosis of autoimmune hepatitis (AIH) may be challenging. However, early diagnosis is
important because immunosuppression is life‐saving. Diagnostic criteria of the International …
important because immunosuppression is life‐saving. Diagnostic criteria of the International …
[PDF][PDF] Treatment challenges and investigational opportunities in autoimmune hepatitis
AJ Czaja, FB Bianchi, HA Carpenter, EL Krawitt… - …, 2005 - Wiley Online Library
New drugs and advances in molecular biology afford opportunities to upgrade the treatment
of autoimmune hepatitis. The aims of this study were to define treatment problems, identify …
of autoimmune hepatitis. The aims of this study were to define treatment problems, identify …
Acute presentation of autoimmune hepatitis: Does it exist? A published work review
H Takahashi, M Zeniya - Hepatology Research, 2011 - Wiley Online Library
Autoimmune hepatitis (AIH), initially called chronic aggressive hepatitis, is conceptually
classified as a primary chronic disease; periportal fibrous expansion and periportal …
classified as a primary chronic disease; periportal fibrous expansion and periportal …
[PDF][PDF] Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population
M Nakamura, N Nishida, M Kawashima, Y Aiba… - The American Journal of …, 2012 - cell.com
For the identification of susceptibility loci for primary biliary cirrhosis (PBC), a genome-wide
association study (GWAS) was performed in 963 Japanese individuals (487 PBC cases and …
association study (GWAS) was performed in 963 Japanese individuals (487 PBC cases and …
Autoimmune liver diseases in the Asia–Pacific region: Proceedings of APASL symposium on AIH and PBC 2016
A Tanaka, X Ma, O Yokosuka, M Weltman, H You… - Hepatology …, 2016 - Springer
During the 25th annual meeting of the Asia–Pacific Association for the Study of the Liver
(APASL 2016) in Tokyo, we organized and moderated an inaugural satellite symposium on …
(APASL 2016) in Tokyo, we organized and moderated an inaugural satellite symposium on …
[PDF][PDF] Sal‐like protein 4 (SALL4), a stem cell biomarker in liver cancers
T Oikawa, A Kamiya, M Zeniya, H Chikada… - …, 2013 - Wiley Online Library
Liver cancers, including hepatocellular carcinomas (HCCs), cholangiocarcinomas (CCs),
and fibrolamellar HCCs (FL‐HCCs) are among the most common cancers worldwide and …
and fibrolamellar HCCs (FL‐HCCs) are among the most common cancers worldwide and …
Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food …
K Amano, PSC Leung, R Rieger, C Quan… - The Journal of …, 2005 - journals.aai.org
Emerging evidence has suggested environmental factors as causative agents in the
pathogenesis of primary biliary cirrhosis (PBC). We have hypothesized that in PBC the lipoyl …
pathogenesis of primary biliary cirrhosis (PBC). We have hypothesized that in PBC the lipoyl …
Present status of autoimmune hepatitis in Japan-correlating the characteristics with international criteria in an area with a high rate of HCV infection
G Toda, M Zeniya, F Watanabe, M Imawari… - Journal of …, 1997 - Elsevier
Background/Aims: A nationwide survey of autoimmune hepatitis (AIH) was carried out in
Japan. Methods: Four hundred and ninety-six patients were enrolled by questionnaires sent …
Japan. Methods: Four hundred and ninety-six patients were enrolled by questionnaires sent …
Present status of autoimmune hepatitis in Japan: a nationwide survey
M Abe, T Mashiba, M Zeniya, K Yamamoto… - Journal of …, 2011 - Springer
Background A nationwide survey of autoimmune hepatitis (AIH) was conducted in Japan,
and the clinical features of patients with AIH were analyzed. Methods A total of 1,056 …
and the clinical features of patients with AIH were analyzed. Methods A total of 1,056 …
The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis: a prospective, multicenter study
S Iwasaki, H Ohira, S Nishiguchi, M Zeniya… - Hepatology …, 2008 - Wiley Online Library
Aim: Treatment with ursodeoxycholic acid (UDCA) improves the survival of stage I and II
primary biliary cirrhosis (PBC) patients. However, new therapeutic options are needed for …
primary biliary cirrhosis (PBC) patients. However, new therapeutic options are needed for …